Booth No.6J-26
CategoryIngredients

Whale Corporation

Booth No.:6J-26
Category:Ingredients
Company Information
Email: qin.yi@whalecorporation.com TEL: +86-186-1010-6369 Address: Whale Corp Building., No.11 HaiYing Road., Feng Tai District., Beijing CHINA URL: https://www.whalecorporation.com
Headquartered in Beijing, China, Whale Corporation is an industry leader providing high-quality, timely CRDMO (Contract Research, Development, Manufacturing, and Outsourcing) services for pharmaceutical intermediates and APIs; Whale Corporation specializes in a wide range of chemical reactions: catalytic hydrogenation, bromination, chlorination, diazotization, oxidation, reduction, metal reagents like Grignard, lithium, and zinc, noble metal coupling, Friedel-Crafts reactions, acyl chloride formation, photochemistry, heterocyclic chemistry, and etc. The company's facilities and well-established reaction conditions enable handling of temperatures from -100°C to 240°C and pressures from 0 to 30 atm, including anhydrous and oxygen-free reactions.

Company information

Address Whale Corp Building., No.11 HaiYing Road., Feng Tai District., Beijing CHINA
TEL +86-186-1010-6369
URL https://www.whalecorporation.com
Email qin.yi@whalecorporation.com
Product introduction Beraprost Sodium; API; cas:88475-69-8New
Eliglustat; API; cas:491833-29-5New
Sodium Stearyl Fumarate; API; cas:4070-80-8New
Methotrexate; API; cas:59-05-2New
Abrocitinib; Intermediates; cas:23761-23-1New
Dacarbazine & Temozolomide; Intermediates; cas:72-40-2New
Niraparib; Intermediates; cas:138229-59-1; 1171197-20-8;New
Apixaban; Intermediates; cas:881386-01-2; 1267610-26-3 New
Dotinurad; Intermediates; cas:37908-97-7New
Sofpironium Bromide; Intermediates; cas:64471-45-0New
Ramelteon; Intermediates; cas:196597-78-1New
Paliperidone; Intermediates; cas:130049-82-0; 84163-13-3; 63234-80-0New
Tegoprazan; Intermediates; cas:2168520-25-8; 942195-86-0New
Zavegepant; Intermediates; cas:855778-84-6; 349535-15-5New
isopropyl3-oxocyclobutane-1-carboxylate; cas:130111-95-4New

Product introduction

Beraprost Sodium; API; cas:88475-69-8NewEliglustat; API; cas:491833-29-5NewSodium Stearyl Fumarate; API; cas:4070-80-8NewMethotrexate; API; cas:59-05-2NewAbrocitinib; Intermediates; cas:23761-23-1NewDacarbazine & Temozolomide; Intermediates; cas:72-40-2NewNiraparib; Intermediates; cas:138229-59-1; 1171197-20-8;NewApixaban; Intermediates; cas:881386-01-2; 1267610-26-3 NewDotinurad; Intermediates; cas:37908-97-7NewSofpironium Bromide; Intermediates; cas:64471-45-0NewRamelteon; Intermediates; cas:196597-78-1NewPaliperidone; Intermediates; cas:130049-82-0; 84163-13-3; 63234-80-0NewTegoprazan; Intermediates; cas:2168520-25-8; 942195-86-0NewZavegepant; Intermediates; cas:855778-84-6; 349535-15-5Newisopropyl3-oxocyclobutane-1-carboxylate; cas:130111-95-4New